Literature DB >> 29931751

Basic & Clinical Pharmacology & Toxicology Policy for Experimental and Clinical studies.

Pernille Tveden-Nyborg1, Troels K Bergmann2, Jens Lykkesfeldt1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29931751     DOI： 10.1111/bcpt.13059

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN： 1742-7835            Impact factor:   4.080


× No keyword cloud information.
  40 in total

1.  Stevioside inhibits experimental fibrosis by down-regulating profibrotic Smad pathways and blocking hepatic stellate cell activation.

Authors:  Sael Casas-Grajales; Diana Alvarez-Suarez; Erika Ramos-Tovar; Laura Dayana Buendía-Montaño; Karina Reyes-Gordillo; Javier Camacho; Víctor Tsutsumi; M Raj Lakshman; Pablo Muriel
Journal:  Basic Clin Pharmacol Toxicol       Date:  2019-01-10       Impact factor: 4.080

2.  Ligustrazine Protects Homocysteine-Induced Apoptosis in Human Umbilical Vein Endothelial Cells by Modulating Mitochondrial Dysfunction.

Authors:  Xuesong Fan; Enshi Wang; Jianxun He; Lei Zhang; Xiaoli Zeng; Yuan Gui; Qi Sun; Yang Song; Hui Yuan
Journal:  J Cardiovasc Transl Res       Date:  2019-07-29       Impact factor: 4.132

3.  MIDD0301 - A first-in-class anti-inflammatory asthma drug targets GABAA receptors without causing systemic immune suppression.

Authors:  Nicolas M Zahn; Alec T Huber; Brandon N Mikulsky; Mae E Stepanski; Alexander S Kehoe; Guanguan Li; Melissa Schussman; Mohammed S Rashid Roni; Revathi Kodali; James M Cook; Douglas C Stafford; Douglas A Steeber; Leggy A Arnold
Journal:  Basic Clin Pharmacol Toxicol       Date:  2019-02-21       Impact factor: 4.080

4.  Live cell optical assay for precise characterization of receptors coupling to Gα12.

Authors:  Ikuo Masuho; Nickolas K Skamangas; Kirill A Martemyanov
Journal:  Basic Clin Pharmacol Toxicol       Date:  2019-04-15       Impact factor: 4.080

5.  hUC-MSCs: evaluation of acute and long-term routine toxicity testing in mice and rats.

Authors:  Jianwei Xu; Gang Liu; Xianyao Wang; Ya'nan Hu; Hongyang Luo; Lan Ye; Zhanhui Feng; Chen Li; Menglan Kuang; Lijuan Zhang; Yixia Zhou; Xiaolan Qi
Journal:  Cytotechnology       Date:  2022-01-05       Impact factor: 2.058

6.  1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor, lowers L-NAME-induced hypertension through suppression of angiotensin-converting enzyme in rats.

Authors:  I A Bukhari; B I Alorainey; A A Al-Motrefi; A Mahmoud; W B Campbell; B D Hammock
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-08       Impact factor: 3.507

7.  Letrozole targets the human ether-a-go-go-related gene potassium current in glioblastoma.

Authors:  Tyler Shugg; Nimita Dave; Enoch Amarh; Abdullah A Assiri; Karen E Pollok; Brian R Overholser
Journal:  Basic Clin Pharmacol Toxicol       Date:  2020-10-27       Impact factor: 4.080

8.  Drug-drug interaction of atazanavir on UGT1A1-mediated glucuronidation of molidustat in human.

Authors:  Dorina van der Mey; Michael Gerisch; Natalia A Jungmann; Andreas Kaiser; Kenichi Yoshikawa; Simone Schulz; Martin Radtke; Silvia Lentini
Journal:  Basic Clin Pharmacol Toxicol       Date:  2020-12-12       Impact factor: 4.080

9.  Combination of bis (α-furancarboxylato) oxovanadium (IV) and metformin improves hepatic steatosis through down-regulating inflammatory pathways in high-fat diet-induced obese C57BL/6J mice.

Authors:  Quan Liu; Linyi Li; Lihui Gao; Caina Li; Yi Huan; Lei Lei; Hui Cao; Ling Li; Anli Gao; Shuainan Liu; Zhufang Shen
Journal:  Basic Clin Pharmacol Toxicol       Date:  2021-03-14       Impact factor: 4.080

10.  Aortic butyrylcholinesterase is reduced in spontaneously hypertensive rats.

Authors:  K Szmicseková; L Bies Piváčková; Z Kiliánová; Ľ Slobodová; P Křenek; A Hrabovská
Journal:  Physiol Res       Date:  2021-09-10       Impact factor: 1.881
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.